脑机行业12月将迎重要大会，多家上市公司出席，产业正与政策趋势共振

Event Overview - The Fifth Brain Science Frontier and Industry Conference will be held in Shenzhen from December 28 to 29, 2025, focusing on brain science, technology, health, intelligence, diseases, and rehabilitation [1] Industry and Policy Trends - The brain-machine interface industry is entering a phase of resonance between industry and policy, with significant government support [3] - In July, a joint opinion was released by seven departments, including the Ministry of Industry and Information Technology, to promote innovation in the brain-machine interface industry [3] - The brain-machine interface has been included as one of the six major directions in the national strategic plan for future industries [3] - In June, China became the second country globally to enter the clinical trial phase for invasive brain-machine interface technology [3] - The "North Brain No. 1" GCP multi-center clinical trial was launched in October, marking a significant advancement in semi-invasive brain-machine systems [3] Market Potential - According to McKinsey, the global market for brain-machine interfaces in the medical application sector is expected to reach $40 billion by 2030 and exceed $145 billion by 2040 [5] - By 2027, breakthroughs in key technologies for brain-machine interfaces are anticipated, establishing advanced technical, industrial, and standard systems [5] Investment Landscape - Current investment events in China's brain-machine interface industry are primarily concentrated in the A round and earlier, with the highest number of angel round investments [3] - Over half of the funding is directed towards invasive overall solutions, followed by brain-like chips and non-invasive brain-machine interface solutions [3] Stock Performance - The stock of leading innovative medical companies has seen a rise of over 65% in the eight trading days following the release of the government opinion [5] Related Stocks - A list of relevant stocks in the industry has been compiled by Zhongyou Securities [7]